ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,202Medicare Part D Prescriptions Filled, Including Refills

Rank: 429 out of 3647

$720K Total Retail Price of All Prescriptions

Rank: 520 out of 3647

587 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 13,376 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 831 763 1 1
LOSARTAN POTASSIUM 584 523 2 11
METOPROLOL TARTRATE 507 489 3 7
LISINOPRIL 484 442 4 4
OMEPRAZOLE 449 393 5 3
AMLODIPINE BESYLATE 428 384 6 2
HYDROCHLOROTHIAZIDE 403 381 7 9
LEVOTHYROXINE SODIUM 402 381 8 5
FUROSEMIDE 398 330 9 8
METFORMIN HCL 358 327 10 6
POTASSIUM CHLORIDE 347 289 11 24
CRESTOR 299 290 12 19
SPIRONOLACTONE 280 250 13 77
HYDROCODONE-ACETAMINOPHEN 255 211 S3 14 12
RANITIDINE HCL 224 188 15 29
HYDRALAZINE HCL 210 187 16 81
ATENOLOL 208 158 17 10
ALENDRONATE SODIUM 200 196 18 23
GLIMEPIRIDE 190 182 19 45
WARFARIN SODIUM 168 151 20 15
ATORVASTATIN CALCIUM 146 138 21 13
TRAMADOL HCL 143 138 22 22
CARVEDILOL 143 137 22 20
DILTIAZEM ER 143 132 22 167
LOVASTATIN 143 140 22 21
NAMENDA 141 141 26 49
TAMSULOSIN HCL 138 137 27 28
CLONIDINE HCL 135 129 28 46
CITALOPRAM HBR 134 108 29 25
KLOR-CON 10 132 115 30 106
INSULIN SYRINGE 131 115 31 76
DOXAZOSIN MESYLATE 127 107 32 57
PRAVASTATIN SODIUM 126 108 33 16
GABAPENTIN 126 114 33 17
FLUTICASONE PROPIONATE 118 109 35 32
BENAZEPRIL HCL 110 110 36 71
DIGOXIN 104 104 37 51
CLOPIDOGREL 99 80 38 26
BUSPIRONE HCL 96 82 39 162
FAMOTIDINE 94 66 40 61
METOPROLOL SUCCINATE 91 84 41 18
NEXIUM 90 65 42 44
PLAVIX 84 70 43 39
ALLOPURINOL 83 68 44 37
PAROXETINE HCL 82 74 45 60
VERAPAMIL ER 81 73 46 99
ZOLPIDEM TARTRATE 80 69 47 14
PREDNISONE 80 60 47 43
ISOSORBIDE MONONITRATE ER 79 66 49 56
DONEPEZIL HCL 79 79 49 30
CIPROFLOXACIN HCL 75 63 51 53
SYNTHROID 69 69 52 42
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 63 53 183
PROPRANOLOL HCL 63 48 53 156
LANTUS 62 58 55 59
GLYBURIDE 61 46 R 56 54
SERTRALINE HCL 58 47 57 27
CAPTOPRIL 57 57 58 193
CYMBALTA 55 25 59 79
DILTIAZEM 24HR ER 51 43 60 164
FENOFIBRATE 50 43 61 50
ENALAPRIL MALEATE 50 50 61 35
SPIRIVA 50 45 61 93
LANTUS SOLOSTAR 50 22 61 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.